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in neuroblastoma cells (SK-N-MC)
chronically exposed to HIV-1
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Upal Roy*, Venkata S. R. Atluri, Marisela Agudelo, Adriana Yndart, Zaohua Huang and
Madhavan Nair*
Department of Immunology, Institute of NeuroImmune Pharmacology, Centre for Personalized Nanomedicine, Herbert
Wertheim College of Medicine, Florida International University, Miami, FL, USA
Background: HIV-associated neurological disorder (HAND) has long been recognized
as a consequence of human immunodeficiency virus (HIV) infection in the brain. The
pathology of HAND gets more complicated with the recreational drug use such as
cocaine. Recent studies have suggested multiple genetic influences involved in the
pathology of addiction and HAND but only a fraction of the entire genetic risk has been
investigated so far. In this regard, role of DJ1 protein (a gene linked to autosomal recessive
early-onset Parkinson’s disease) in regulating dopamine (DA) transmission and reactive
oxygen species (ROS) production in neuronal cells will be worth investigating in HIV-1
and cocaine exposed microenvironment. Being a very abundant protein in the brain, DJ1
could serve as a potential marker for early detection of HIV-1 and/or cocaine related
neurological disorder.
Methods: In vitro analysis was done to observe the effect of HIV-1 and/or cocaine on
DJ1 protein expression in neuroblastoma cells (SK-N-MC). Gene and protein expression
analysis of DJ1 was done on the HIV infected and/or cocaine treated SK-N-MC and
compared to untreated cells using real time PCR, Western Blot and flow cytometry. Effect
of DJ1 dysregulation on oxidative stress was analyzed by measuring ROS production in
these cells.
Results: Gene expression and protein analysis indicated that there was a significant
decrease in DJ1 expression in SK-N-MC chronically exposed to HIV-1 and/or cocaine
which is inversely proportional to ROS production.
Conclusion: This is the first study to establish that DJ1 expression level in the neuronal
cells significantly decreased in presence of HIV-1 and/or cocaine indicating oxidative
stress level of DA neurons.
Keywords: HIV-1, HIV-associated neurological disorder, cocaine, DJ1, Parkinson’s disease, SK-N-MC
Introduction
The introduction of antiretroviral therapy (ART) has significantly improved the morbidity and
mortality of human immunodeficiency virus (HIV) infected patients; however, the virus still persists
in reservoirs like the brain even in ART treated patients (Best et al., 2009; Varatharajan and
Thomas, 2009; Kanmogne et al., 2012). One of the major neurological disorders that are most
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frequently observed in patients with ART therapy is HIV-
associated neurological disorder (HAND; Everall et al., 2009;
Roy et al., 2013). The molecular mechanisms of cognitive
impairment during HIV infection are still unclear, although
previous studies have indicatedHIV-associated inflammation and
neurodegenerative pathology in the brain of HAND patients
(Grant, 2008; Robinson-Papp et al., 2008). Few studies have
assessed the genetic risk factors that are associated with
cognitive impairment among HIV-1 infected patients although
there is no clear clinical correlation (Payton, 2006). There
are some accumulating evidences suggesting that HIV-1 and
ART may facilitate the development of neurodegenerative
disease like Parkinson disease (PD) via many signaling mecha-
nisms including but not limited to inflammation, mitochondrial
dysfunction, and interference with ubiquitin proteasome pathway
(Brew et al., 2009; Tisch and Brew, 2009; Wilhelmus et al.,
2012). Persistent low levels of HIV replication in presence
of ART might predispose host to neurodegeneration through
low level of neuro inflammation (Brew et al., 2009). Several
groups have reported increasing incidences of HIV related to
cognitive impairment among virally suppressed HIV patients
who are on ART for a longer period of time (Cysique et al.,
2006; Tisch and Brew, 2009). This phenomenon also poses an
increasing challenge on identifying or treating HIV infected
patients with neurological disorders. HAND possesses many
distinct neurological disorders including cognitive impairment,
behavioral abnormalities and motor disorders which is also very
common in PD (Price, 1996; Cysique et al., 2006). Both PD and
HIV infection have a common anatomical target in the brain
called substantia nigra and a common neurochemical disturbance
called dopamine (DA) deficiency (Brew et al., 2009; Gago et al.,
2011).
The DA deregulation was also observed in cocaine addicted
patients who are infected with HIV makes this clinical scenario
relatively more complex (Nair et al., 2005). A permanent
imbalance in DA level in the brain due to chronic cocaine
addiction can also add one another layer of complexity in
detecting neurodegenerative diseases especially during HIV
infection (Meade et al., 2015). Thus, the key factor that regulates
all these functions will be of prime importance to understand
this highly complicated disease pathology. In order to address
this issue, we have investigated DJ1, a protein that is abundant
in the brain and also a key regulator of DA transmission and
reactive oxygen species (ROS) balance (Blesa and Przedborski,
2014; Lopert and Patel, 2014; Sun et al., 2014).
DJ-1 (PARK7) is a neuroprotective protein that protects cells
from oxidative stress (Lopert and Patel, 2014; Sun et al., 2014).
Initially, DJ-1 gene was linked to autosomal recessive early-onset
of PD. It is a homodimeric protein belonging to the Thi/Pfp1 super
family, highly conserved in most living things from human beings
to Escherichia coli and is localized in the cytoplasm, nucleus, and
mitochondria (Requejo-Aguilar et al., 2015). Although its normal
physiological function is not entirely known, it has been shown
to be involved in DA neurotransmission, particularly through
the dopamine transporter (DAT). It normally inhibits reuptake
of DA through DAT which helps in maintaining DA levels in
the brain. The protective role of DJ-1 against oxidative stress is
well known in PD (Hering et al., 2004; Liang et al., 2007). DJ1
protects neurons from oxidative stress by scavenging H2O2 from
neuronal environment and thus it also protects mitochondrial
integrity in these cells (Schapira, 2009; Vasseur et al., 2009;
Wilhelmus et al., 2012). Most importantly, DJ-1 is ubiquitously
expressed throughout the body including the brain (Schulte and
Gasser, 2011). All these observations explain that DJ1 tries to
regulateDA transmission in the brainwhich could get deregulated
with the addiction of drugs like cocaine. At the same time, DJ1
also regulates oxidative stress which is highly affected by HIV
infection in the brain (Brew et al., 2009). Considering these
two important factors, it is crucial to investigate if DJ1 has
any role in controlling neuronal functioning and homeostasis
during HIV infection and cocaine treatment. In the present
study, we have demonstrated a direct effect of HIV-1 and/or
cocaine on DJ1/PARK7 expression and function that may be
associated with neuronal damage and associated disorders. This
studywill potentially increase our understanding of the role ofDJ1
in neuronal dysregulation during HIV-1 infection and cocaine
abuse.
Materials and Methods
Cell Culture and Reagents
Humanneuroblastoma SK-N-MCcells were obtained fromATCC
(ATCC Cat # HTB-10) and cultured in Eagle’s minimum essential
medium (MEM; catalog # 30-2003) supplemented with fetal
bovine serum to a final concentration of 10% (catalog # 30-
2020) and 1% antibiotic/antimycotic solution (Sigma-Aldrich, St.
Louis, MO, USA). HIV-1Ba-L (clade B) (NIH AIDS Reagent
Program Cat. # 510) was obtained through AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID, NIH.
Park7 primer was obtained from life technologies, NY, USA (Cat.
# 4331182,Hs00994896_g1). DJ1 antibody (#2134)was purchased
fromCell Signaling Technology, Inc, USA. Cocaine hydrochloride
was obtained from Sigma (Cat# C5776).
HIV-1 Exposure and Cocaine Treatment of
SK-N-MC Cells
SK-N-MC cells were exposed to HIV-1 using the previously
described protocol (Ohagen et al., 1999; Eugenin and Berman,
2007; Atluri et al., 2013, 2014; Kurapati et al., 2013) with slight
modifications. Briefly, SK-N-MC (1  106 cells) cells were
cultured overnight in T-75 flasks using MEM. SK-N-MC cells
were initially exposed to three different concentrations of HIV-1
(50, 100, and 300 ng) in order to observe the effect of DJ1 gene
expression in presence of HIV. After 24 h of HIV exposure, cell
pellet was collected for RT-PCR analysis. Based on dose of HIV
that showed highest expression of DJ1, further experiments were
designed. In parallel experiment, increasing doses of cocaine (10,
100, 1000, and 3000 nM) were used to treat SK-N-MC cells for
24 h as per previous established protocol (Gandhi et al., 2010).
At the end of incubation, cells were used for RT-PCR analysis
as mentioned above. A graphical representation was made with
respect to fold change of gene expression in response to different
concentration of cocaine. Further experiments were designed
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with the cocaine concentration that showed highest response to
DJ1 gene expression.
Finally, SK-N-MC cells were exposed to pre-optimized doses of
HIV-1 and cocaine separately and in combination for 24 and 72 h,
respectively. In case of co-incubation, HIV-1 and cocaine were
added to the cells simultaneously at once and no fresh media was
added during the entire period of incubation in order to maintain
the concentration. At the end of incubation, cells were harvested
for RT-PCR, Western blot and flow-cytometric analysis at 72 h
post incubation.
In order to observe the viral replication in SK-N-MC, cells
were exposed to a pre-optimized concentration of HIV-1 as per
published protocol with a little modification (Harouse et al., 1995;
Alvarez Losada et al., 2002; Atluri et al., 2014). Initially, SK-
N-MC were exposed to HIV-1 for 12 h. After incubation, cells
were washed with phosphate buffer (PBS) twice to remove any
unattached virus and incubated for 5 days with freshmedia. Every
48 h, half of the medium was replaced with the fresh medium and
the supernatant obtained from the used medium was used for the
p24 antigen estimation using ELISA kit (ZeptoMetrix Corp. Cat #
0801200). Control (unexposed) cells were included in the set-up of
all experiments. Viral replicationwasmeasured in cell supernatant
with respect to p24 level at different time points (day 1, 3, and 5)
and graphical representation was made for p24 (pg/ml) vs. days of
incubation.
Quantitative Real Time PCR
Gene expression was quantitated using real time PCR. Upon
desired treatment period, cells were harvested, RNA from cell
pellets was extracted using RNeasy mini kit (Qiagen, GmbH,
Germany) followed by cDNA synthesis using high capacity
reverse transcriptase cDNA kit (Applied Biosystems) to perform
quantitative real time PCR (qRT-PCR) using Taqman gene
expression assays (Applied Biosystems) for DJ1 (Hs00994896_g1)
and GAPDH (Hs99999905_m1). GAPDH was served as an
internal control. Relative abundance of each mRNA species was
assessed using brilliant Q-PCR master mix from Stratagene with
Mx3000P instrument which detects and plots the increase in
fluorescence vs. PCR cycle number to produce a continuous
measure of PCR amplification. Relative mRNA species expression
was quantitated and the mean fold change in expression of DJ1
genewas calculated using the comparative CTmethod (Transcript
Accumulation Index, TAI= 2-CT). All data were normalized
with an endogenous reference gene, GAPDH. In addition, results
on RNA from treated samples were normalized with control
(untreated sample).
DJ1 Protein Levels by Western Blot Analysis:
For SDS-PAGE, similar amounts of control and test group SK-
N-MC cellular protein, typically 40 mg per lane were used. All
the protein samples were separated by using Any KD Mini-
Protean TGX precast Gels (Bio-Rad, Cat # 456–9034). Proteins
were transferred to nitrocellulose membranes, and the quality of
protein measurement, electrophoresis, and transfer was checked
by staining with Ponceau S. Membranes were blocked with 5%
skimmed milk in TBS-T (20 mM Tris buffer, pH 7.5, 0.5 M NaCl,
0.1% Tween 20) for 1 h at room temperature and incubated at 4°C
overnight in the anti-DJ1 primary antibody (Cell signaling, cat #
2134) 1/1000 diluted in 2% skimmedmilk in TBS-T. Subsequently,
blots were washed in TBS-T (four times, 10 min each) and
incubated for 1 h at room temperature in horse radish peroxidase-
goat anti-rabbit antibody (Promega, Cat #W401B) diluted 1/2500
in 2% skim milk in TBS-T. After additional washings, protein
bands were detected by chemiluminiscence using SuperSignal
West Pico Luminol/Enhancer (Thermo Scientific, Cat # 1856136)
and SuperSignal West Pico substrate (Thermo Scientific, Cat
# 1856135). ImageJ software was used to quantify the protein
expression on the blot and expressed as a fold change with respect
to treatment.
Intracellular DJ1 Protein Analysis by Flow
Cytometry
To assess the levels of DJ1 protein in SK-N-MC, the cells
were treated with HIV-1 (100 ng) and/or cocaine (1 mM)
for 72 h. The cells were then harvested and counted; equal
number of cells (1  106) were aliquoted in 12 mm  75 mm
polystyrene falcon tubes (catalog # 352058, BD Biosciences,
San Jose, CA, USA), blocked with 1:1 ratio of human and
normal goat serum (Chemicon International, Temecula, CA,
USA), fixed and permeabilized with Cytofix/Cytoperm solution
(BD Bioscience). The DJ1 protein was detected with primary
monoclonal antibody, rabbit anti-DJ1 (Cell Signaling, CA, USA)
and secondary antibody, FITC-conjugated goat anti-rabbit IgG
antibody (Millipore). Cells were acquired on an Accuri C6
instrument (BD Accuri, Ann Arbor, MI, USA) and analyzed
with FloJo software (Tree Star, INC, Ashland, OR, USA). A
total of 10,000 events were collected for each sample. Cells
were gated based on unlabeled and secondary antibody controls.
Cells positive for specific protein are shown in the histogram
overlay with shifted mean fluorescence intensity compared to
controls.
Effect of HIV-1 and/or Cocaine on ROS
Production in SK-N-MC
Reactive oxygen species production following exposure to HIV-1
and/or cocaine in SK-N-MC were detected using dichloro-
fluorescein diacetate assay (DCF-DA; Molecular Probes, Eugene,
OR, USA) as per published protocol (Agudelo et al., 2011). Cells
were cultured in 96-well plates (100,000 cells/well) overnight
to allow them to adhere on the surface of the well. The next
day, cells were treated with optimized concentration of HIV-1
and/or cocaine for 24 and 72 h, respectively, without changing
media during incubation. After incubation, cells were washed and
treated with antioxidant, catalase (0.001 mg) for 2 h. Next, the
cells were washed and treated with DCF-DA (100 mM) for 1 h at
37°C and finally read in a BioTek Synergy HT microplate reader
(excitation 485 nm and emission 528 nm; BioTek, Winooski, VT,
USA). Cells treated with H2O2 (50 mM) for 2 h was considered as
positive control. Furthermore, fluorescence was visualized in an
Olympus IX51microscope (OlympusAmerica Inc., Center Valley,
PA, USA) and images captured and analyzed with the Qimaging
camera and software (QImaging, British Columbia, Canada).
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FIGURE 1 | Acute exposure of HIV-1 increased DJ1/PARK7 expression
in SK-N-MC cells. Different concentrations of HIV-1 were exposed
(50–300 ng) to SK-N-MC cells for 24 h. RT-PCR data represented with
respect to fold changes in gene expression compared to control. The fold
change expression was found to be statistically significant (*p < 0.05).
Data Analysis
PCR analysis was performed at least three times and the values
obtained were averaged. Protein analysis (Western Blot and flow
cytometry) was done at least three times in order to obtain
quantitative analysis of the protein blot and to measure the fold
change in protein expression. In the western blot, proteins relative
band density was measured by using ImageJ software. All the
results were expressed as mean  standard error of the mean.
Statistical analysis of two groups was performed by Student’s t-
test, while more than two groups were analyzed using one way
ANOVA. Differences were considered significant at p  0.05. If
the combined effect observed is significantly greater/less than the
expected (additive) effect, it was considered synergism (Tallarida,
2011). Data analysis was performed with the Statistical Program,
GraphPad Prism software (La Jolla, CA, USA).
Results
DJ1 Expression Increased in Presence of HIV-1
SK-N-MC cells were exposed to three different concentrations
of HIV-1 virus (10, 100, and 300 ng) for 24 h. At the end
of the incubation cells were harvested and used for qRT-PCR
analysis. Gene expression was measured with respect to the fold
change compared to experimental control. GAPDH was kept as
internal control for this experiment. The data indicated that with
increasing concentrations of virus there was an increase in DJ1
expression up to 100 ng (p  0.05). However, increase in gene
expression beyond that concentration was not significant (300 ng;
Figure 1). Thus, 100 ng was considered to be optimum for further
experimental analysis.
Exposure of Cocaine Increased DJ1 Expression
SK-N-MC cells were exposed to four different concentrations
of cocaine (10, 100, 1000, and 3000 nM) for 24 h. At the
FIGURE 2 | Acute treatment of cocaine increased DJ1/PARK7 gene
expression in SK-N-MC cells. Different concentrations of cocaine
(10 nM–3 mM) were exposed to SK-N-MC cells for 24 h and gene expression
data were represented with respect to fold change compared to control. The
gene expression data was statistically validated with unpaired t-test and
statistical significance (p values) indicated in the order of **p < 0.05,
*p < 0.005.
end of incubation, cells were harvested for RT-PCR analysis.
As mentioned above, the comparative gene expression analysis
was done with respect to delta delta ct values of PCR data
keeping GAPDH as internal control. Data represented in Figure 2
indicates that in 10 nM–3 mM of cocaine treatment there was
significant increase of DJ1 gene expression compared to control
within 24 h incubation (p < 0.001). In this regard, 1 mM
concentration was considered as optimum concentration for
further study.
DJ1 Expression Decreased in Presence of HIV-1
and Cocaine
SK-N-MC cells were treated with cocaine (1mM), HIV-1 (100 ng)
separately and in combination for 24 and 72 h, respectively.
Untreated SK-N-MC were used as control. After incubation,
cells were washed out and cell pellets were collected for qRT-
PCR analysis. Compared to untreated/uninfected control, HIV-
1 or cocaine independently increased the DJ1 gene expression
(Figure 3A). However, the combined effects of HIV-1 and cocaine
significantly decreased the DJ1 expression especially 72 h post
treatment (p = 0.0006). In order to observe the HIV replication
in SK-N-MC cells, 100 ng of HIV-1 was exposed to these cells and
p24 level were measured up to 5 days post infection as explained
in method section. The p24 level data indicated that there was
subsequent increase in viral replication up to 72 h (Figure 3B).
Therefore, following experiments were done after incubation of
72 h.
Exposure of HIV-1 and/or Cocaine Decreased
DJ1 Protein (Western Blot)
SK-N-MC cells were grown in T-75 culture flask and treated
with HIV-1 (100 ng) and/or cocaine (1 mM), respectively, for
72 h. At the end of the incubation, the cells were harvested
and cell pellets were collected from respective treatments for
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FIGURE 3 | Exposure of HIV-1 and cocaine significantly decreased
DJ1/PARK7 expression in SK-N-MC cells. (A) SK-N-MC cells were
exposed to HIV-1 (100 ng), cocaine (1 mM) and HIV-1 with cocaine,
respectively in order to observe the gene expression after 24 h (black) and
72 h (red) of incubation. RT-PCR data was represented with respect to fold
change as compared to control. Statistical significance was calculated with
unpaired t-test and p values were expressed in as **p = 0.009,
***p = 0.0006. (B) HIV-1 exposure to SK-N-MC indicated that there was
significant increase of p24 level up to day 3 (72 h) indicating viral replication
within these cells (**p < 0.05).
Western Blot analysis. Western blot was developed with the
help of anti-human DJ1 antibody (Cell signaling, USA) and
GAPDHwas used as internal control (Figure 4A). The volumetric
analysis of western blot indicated that DJ1 protein expression
was significantly inhibited with the exposure of HIV-1. At the
same time, the synergistic effects of HIV-1 and cocaine have
further reduced the DJ1 expression in SK-N-MC cells which was
significantly lower than untreated cells and HIV-1 exposed cells
(p < 0.0005; Figure 4B). This observation strongly indicated that
the HIV-1 and cocaine have dramatically inhibited the expression
of DJ1 protein in SK-N-MC cells.
Effect of HIV-1 and/or Cocaine on DJ1 Protein
Expression on SK-N-MC Cells (Flow Analysis)
Flow cytometric analysis of intracellular DJ1 protein in HIV-1
and/or cocaine exposed cells correlatedwith theWestern blot data.
FIGURE 4 | Combined effect of HIV-1 and cocaine markedly decreases
DJ1 protein expression in SK-N-MC cells as measured by western
blot and flow cytometry. (A) Protein profile of DJ1 gene in SK-N-MC
exposed to HIV-1 (100 ng) and/or cocaine (1 mM). (B) Volumetric analysis of
Western Blot data with respect to fold change compare to untreated cells
(control). Significance values were represented as *p < 0.05, **p < 0.005,
***p < 0.0005, ****p < 0.0001. (C) Representative overlay histogram of the
total cells stained with primary monoclonal antibody, rabbit anti-DJ1 and
secondary antibody, FITC-conjugated goat anti-rabbit IgG. The light gray
dotted line histograms represent the secondary antibody control; the black
line histogram represents the untreated/uninfected control; the green
histogram represent the cocaine treated cells; the red histogram represents
the HIV infected cells; and the blue histogram represents the cocaine treated
and HIV infected cells. 10,000 events were acquired. Data are representative
of three independent experiments.
Intracellular levels of DJ1 decreased after 72 h exposure to HIV-1
and/or cocaine (Figure 4C). Furthermore, the combined effects of
HIV-1 and cocaine caused a significant decrease inDJ1 expression
compared to the individual treatment and control. Thus, the DJ1
down-regulation in SK-N-MC cells indicates a direct suppressive
effect of cocaine and HIV.
Exposure of HIV-1 and/or Cocaine Increases ROS
Production in SK-N-MC Cells
DJ1 is one of the major regulator of ROS production in neuronal
cells (Lopert and Patel, 2014). SK-N-MC cells were exposed
to HIV-1 and/or cocaine for 24 and 72 h, respectively. At the
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A
B
FIGURE 5 | HIV-1 and/or cocaine exposure enhanced ROS
production in SK-N-MC cells after 24 and 72 h. (A) HIV-1 and
cocaine induced ROS production was observed in SK-N-MC. Cells were
pretreated with H2O2, catalase, HIV-1, cocaine and HIV-1+cocaine,
respectively. The fluorescence was detected at 485 excitation and at 528
emission spectra. Images were representative of four independent
experiments. (B) SK-N-MC cells were exposed to predetermined
concentration of HIV-1 and cocaine for 24 and 72 h, respectively. At the
end of the incubation ROS production was measured in treated cells and
compared with untreated control. H2O2 treatment was served as a
positive control and Catalase as an antioxidant. Data are expressed as
mean  SE of relative fluorescence units (RFU) values of four
independent experiments. The statistical significance were expressed as
p values (**p < 0.0001).
end of the incubation, cells were used to perform ROS assay
as per previously published protocol (Agudelo et al., 2011). In
this study, we have observed an increase in the ROS productions
after treatment with HIV-1 and/or cocaine, which indicates that
there is a certain amount of ROS imbalance in SK-N-MC cells
after cocaine treatment andHIV-1 exposure. Fluorescence images
were captured with an Olympus IX51 microscope indicating
the retention of oxidized DCF reagent in the cell. As per
protocol, reduced form of DCF is non-fluorescent until it
gets oxidized with the help of intracellular esterases of treated
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cells. Therefore, higher retention of oxidized-DCF in HIV-1,
cocaine, and HIV-1+cocaine treated cells was indicative of ROS
production compared to untreated cells. The H2O2 treated cells
served as a positive control for ROS production (Figure 5A).
The intracellular fluorescence of treated cells were detected by
microplate reader and expressed as mean relative fluorescence
units (RFU) with respect to different treatments as explained in
Figure 5B. The comparative analysis of ROS production between
24 and 72 h did not show any significant difference in the HIV-
1 and/or cocaine treated cells. Nonetheless, there was substantial
increase in ROS production with exposure to HIV-1 or cocaine
and in combination compared to untreated cells (p< 0.0001).
Discussion
Neurocognitive impairment has long been recognized as a
consequence of HIV-1 infection. Combination ART has altered
the pathological manifestation of HIV to a great extent;
however, virus still persists in the brain and can cause neuronal
abnormalities. Therefore, it is very important to understand the
molecular mechanisms of virus mediated neuronal defects. Ever
since ART became widely available in developed countries, HIV
associated dementia (HAD) has become quite rare, observed
in only 2–3% of patients in research studies. However, the
subtler forms of HAND remain frequent and become more
likely with increasing age (Devlin et al., 2012; Hargus and
Thayer, 2013). In this regard, there are several studies that
have investigated potential biomarkers for early detection of
neurocognitive impairment in HIV infected patients (Hinkin
et al., 2008; Kusao et al., 2012) while there are very limited
studies that have investigated genetic factors thatmight be affected
by HIV infection and/or cocaine abuse. Considering the close
connection of DA transmission and ROS regulation by DJ1, we
focused on the role of DJ1 in HIV and/or drug addiction. In
this regard the present study indicated for the first time that
gene expression of PARK7/DJ1 is significantly upregulated with
cocaine and HIV exposure after 24 h of incubation (Figures 1 and
2). Up-regulation of PARK7/DJ1 with acute exposure of HIV-1
or cocaine indicated the active involvement of DJ1 in regulating
the ROS production in neuronal cells. These results corroborated
with previous studies, which have also shown the role of DJ1 in
regulating the balance of ROS in the brain (Liang et al., 2007;
Lopert and Patel, 2014). However, further detailed investigation
on the chronic effect of HIV and cocaine exposure showed
inhibitory effect onDJ1 gene in SK-N-MC.When optimized doses
of HIV-1 (100 ng) and/or cocaine (1 mM) were used to treat SK-
N-MC cells for 24 and 72 h, there was a synergistic effect of these
two factors in reducing the DJ1 gene expression due to prolong
exposure of HIV-1 and cocaine (Figure 3A; p = 0.0006). It is
noteworthy that combined effect of HIV-1 and cocaine was more
significant on DJ1 expression at 72 h post incubation compared
to 24 h. However, we acknowledge the fact that DJ1 expression
level was variable between 24 and 72 h with HIV-1 exposure
alone (Figure 3A). It has been demonstrated previously that SK-
N-MC get infected with both R5 and X4 strains of HIV-1 in
chemokine receptors dependent and the independent pathways
(Harouse et al., 1995; Alvarez Losada et al., 2002; Atluri et al.,
2014). The present study also demonstrated an increase in HIV-1
replication (p24 level) in SK-N-MC up to 72 h which may have an
effect in DJ1 down regulation along with cocaine which is subject
to further investigation (Figure 3B). Based on these observations;
further characterization was done 72 h post incubation.
The DJ1 gene down-regulation was further validated with
protein profile of the DJ1 expression in SK-N-MC cell lysate
as measured by Western blot and flow-cytometry, respectively
(Figure 4). The western blot analysis indicated that there was
significant decrease in DJ1 expression with HIV-1 exposure up to
72 h (Figure 4A). This data correlated with the HIV-1 p24 level
data indicating chronic exposure of HIV significantly decreased
DJ1 expression. More importantly, the combined exposures of
HIV-1 and cocaine have greatly reduced the DJ1 expression
indicating the direct effect as described in Figure 4A. The
volumetric analysis of the protein expression has reestablished
the observation of marked down-regulation of the DJ1 protein
that was statistically significant (p < 0.0005; Figure 4B). The
protein expression data was corroborated with flow cytometric
analysis of SK-N-MC cells exposed to HIV-1 and/or cocaine
(Figure 4C). The intracellular staining of DJ1 protein in SK-N-
MC cells indicated that with exposure to HIV and cocaine the
DJ1 protein level significantly decreased with 72 h, incubation.
This observation goes in agreement with our western blot data
suggesting chronic exposure of HIV and/or cocaine definitely
reduced the DJ1 expression and possibly their functions. Previous
studies have also indicated that HIV-1 protein Tat and cocaine
exposure induced ROS production in the brain activating various
biochemical pathways including extracellular signal-regulated
kinases or ERK (Aksenov et al., 2006; Dalvi et al., 2014). At the
same time it has also been demonstrated that upregulation of ROS
is a hallmark of neurological disorders and DA receptor toxicity
even inHIV infected patients. These observations alsomarked the
role of ROS and DA dysregulation in HIV infected and cocaine
addicted rat model (Aksenov et al., 2006; Capone et al., 2013). In
the present study, we have observed that there was increased ROS
production in HIV-1 and cocaine exposed SK-N-MC compared
to untreated cells. The qualitative (Figure 5A) and quantitative
(Figure 5B) analysis indicated that HIV-1 and cocaine exposure
significantly induced the ROS production among treated cells up
to 72 h. This observation explained the fact that HIV-1 and/or
cocaine increased ROS production was inversely proportional
to the gene and protein expression of DJ1. Thus, inhibition of
DJ1 protein by HIV-1 and cocaine certainly increased the ROS
production by SK-N-MC cells. However, there were no significant
changes observed in 24 and 72 h ROS production indicating a
chronic imbalance of ROS in these neuronal cells post exposure
to HIV-1 and cocaine. The observation may corroborate the
clinical scenario where de-regulation of ROSwas observed inHIV
infected patients with history of cocaine use (Wang et al., 2013).
Thus the present study brings one step closer in understanding
the molecular mechanisms of elevated ROS production in HIV
infected and cocaine addicted patients. However, authors are also
aware of the fact that ROS is regulated by many other cellular
factors including DJ1. Being a much conserved gene and its
ubiquitous presence in all human cells, it is challenging to identify
the long term effect of DJ1 on ROS production in neurons in vitro.
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In this regard, in vivo studywithDJ1 knockdownmicewill be ideal
to investigate specific molecular pathway involved in HIV-1 and
cocaine mediated DJ1 dysregulation.
Conclusion
HIV-associated neurological disorder among HIV-infected
patients is an increasing problem in developed countries, which
has significant social and economic consideration. Although,
HAART has reduced the frequency of HAD among HIV-infected
patients, there are still different forms of neurological disorder
that persist even in treated patients with cocaine abuse. Since ROS
and DA deregulation have shown to be the key cause of many
neuronal dysfunctions, it has become increasingly important to
understand this phenomenon especially in HIV infected and
cocaine addicted patients. Research investigating the genetic
of neuronal dysfunction is a new and rapidly developing field
that may aid in new therapeutic strategy. However, very few
studies have assessed whether genetic variations are associated
with the early stage of neurological decline among HIV-
infected patients and during cocaine addiction. As the era of
neuronal genetics emerges, this study will bring opportunities
to investigate the role of DJ1 in brain related disorders. In order
to understand the relationship between HIV related neuronal
pathology and recreational drug use, further studies on the
genetics of the neurological dysfunction caused by HIV and
cocaine are needed. Overall, this research may provide new
evidence on the role of DJ1 in HIV-1 and/or cocaine induced
oxidative stress regulation that may provide an important clinical
implication in HIV infected patients with history of drug
abuse.
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